v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
ASSETS    
Cash and cash equivalents $ 41,963 $ 41,619
Restricted cash 1,682 3,666
Principal and interest receivable 11,269 10,354
TBA securities and interest rate futures contracts - at fair value 3,911 240
Other assets 43,412 42,984
Total assets 2,809,981 2,749,778
LIABILITIES    
Notes payable 192,230 218,757
Securities sold under agreements to repurchase 57,000 54,041
Senior unsecured notes 89,251 89,023
TBA securities and interest rate futures contracts - at fair value 0 32
Due to broker 129,359 198,191
Interest payable 1,890 3,423
Income taxes payable 0 0
Total liabilities 2,553,079 2,482,255
STOCKHOLDERS’ EQUITY    
Common stock, $0.01 par value. As of March 31, 2026: 350,000,000 shares authorized, 24,914,647 shares issued and outstanding. As of December 31, 2025: 350,000,000 shares authorized, 24,914,647 shares issued and outstanding. 249 249
Additional paid-in capital 475,000 474,577
Accumulated other comprehensive income (loss) 3,084 (1,314)
Retained earnings (deficit) (221,431) (205,989)
Total stockholders’ equity 256,902 267,523
Total liabilities and stockholders’ equity 2,809,981 2,749,778
Nonrelated Party    
LIABILITIES    
Accrued expenses 2,291 2,021
Affiliates    
LIABILITIES    
Accrued expenses 244 783
Management fee payable to affiliate 1,161 663
Non-recourse    
LIABILITIES    
Non-recourse securitization obligation, collateralized by residential mortgage loans in securitization trusts (see Note 2) 2,079,653 1,915,321
Residential mortgage loans    
ASSETS    
Mortgage loans 245,534 294,134
Residential mortgage loans in securitization trusts    
ASSETS    
Mortgage loans 2,249,614 2,076,776
RMBS - at fair value    
ASSETS    
CMBS, at fair value $ 212,596 $ 280,005